Notes / Company

Cresanto Global Ltd.

RAYLA BSE 531207 ISIN INE741C01017 Pharmaceuticals

Fundamentals

Market cap: ₹1.99 cr
ROE: 6.97%
Debt / equity: -0.92
52-week range: 3.48 — 4.65

The timeline — 1 note on Cresanto Global Ltd.

May 2026

28 May 26 · 1:09 PM IST Brief

Brief · Earnings · Micro cap

Cresanto Global reports zero revenue and negative equity.

The nano-cap firm ended FY26 with a net loss of ₹43.03 lakhs and total assets of less than ₹1 lakh.

Verify on exchange BSE filings for RAYLA NSE filings for RAYLA